| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69315-911-01 | 69315-911 | HUMAN PRESCRIPTION DRUG | OXAZEPAM | OXAZEPAM | CAPSULE | ORAL | 20250709 | N/A | ANDA | ANDA218261 | Leading Pharma, LLC | OXAZEPAM | 10 mg/1 | 100 CAPSULE in 1 BOTTLE (69315-911-01) |
| 69315-912-01 | 69315-912 | HUMAN PRESCRIPTION DRUG | OXAZEPAM | OXAZEPAM | CAPSULE | ORAL | 20250709 | N/A | ANDA | ANDA218261 | Leading Pharma, LLC | OXAZEPAM | 15 mg/1 | 100 CAPSULE in 1 BOTTLE (69315-912-01) |
| 69315-913-01 | 69315-913 | HUMAN PRESCRIPTION DRUG | OXAZEPAM | OXAZEPAM | CAPSULE | ORAL | 20250709 | N/A | ANDA | ANDA218261 | Leading Pharma, LLC | OXAZEPAM | 30 mg/1 | 100 CAPSULE in 1 BOTTLE (69315-913-01) |